A Cuproptosis-Related lncRNAs Signature Could Accurately Predict Prognosis in Patients with Clear Cell Renal Cell Carcinoma
Analytical Cellular Pathology · 22.12.2022 · 2022 · 1-32
DOI: 10.1155/2022/4673514 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Cellular Pathology, erschienen am 22.12.2022. Verfasst von Wei Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, RNA, Long Noncoding, Apoptosis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Applied Basic Research Project of Shanxi Province, China, Program for the Scientific Activities of Selected Returned Overseas Professionals in Shaanxi Province.
Abstract (Originalsprache)
Background
Clear cell renal cell carcinoma (ccRCC) is the most common subtype of kidney cancers. As cuproptosis, a new cell death mechanism proposed recently, differs from all other known mechanisms regulating cell death, we aimed to create prognostic markers using cuproptosis-related long non-coding ribonucleic acids (RNAs; lncRNAs) and elucidate the molecular mechanism.
Methods
Data from transcriptome RNA sequencing of ccRCC samples and the relevant clinical data were downloaded from The Cancer Genome Atlas, and Pearson’s correlation analysis was implemented to obtain the cuproptosis-related lncRNAs. Then, univariate Cox, multivariate Cox, and Least Absolute Shrinkage and Selection Operator Cox analyses were performed to construct the risk signatures. The cuproptosis-related lncRNAs predictive signature was evaluated with receiver operating characteristic curves and subgroup analysis. Finally, Gene Set Enrichment Analysis (GSEA), single-sample GSEA (ssGSEA), tumor immune microenvironment (TIME), and immune checkpoints were performed to explore the relationship between immunity and patient prognosis.
Results
Five cuproptosis-related lncRNAs, including FOXD2-AS1, LINC00460, AC091212.1, AC007365.1, and AC026401.3, were used to construct the signature. In the training and test sets, low-risk groups (as identified by a risk score lower than the median) demonstrated a better prognosis with an area under the curve for 1-, 3-, and 5-year survival being 0.793, 0.716, and 0.719, respectively. GSEA analysis suggested significant enrichment of the tricarboxylic acid cycle and metabolism-related pathways in the low-risk group. Besides, both ssGSEA and TIME suggested that the high-risk group exhibited more active immune infiltration.
Conclusion
We proposed a cuproptosis-related lncRNAs signature, which had the potential for prognoses and prediction. Our findings might contribute to elucidating potential genomic biomarkers and targets for future therapies in the cuproptosis-related signaling pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
- Department of Clinical Medicine, Shanxi Medical University, Taiyuan, Shanxi, China.
- Department of Urology, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
ORCID-Profile: Wei Zhang, Han Wang, Wei Wang, Haoqiang Xue, Maolin Qiao, Liying Song, Shuang Wang, Zhaoyu Ren, Zhifang Ma
Förderung
- Applied Basic Research Project of Shanxi Province, China
- Program for the Scientific Activities of Selected Returned Overseas Professionals in Shaanxi Province
Zitieren
APA
Zhang, W., Wang, H., Wang, W., Xue, H., Qiao, M., Song, L., Wang, S., Ren, Z., & Ma, Z. (2022). A Cuproptosis-Related lncRNAs Signature Could Accurately Predict Prognosis in Patients with Clear Cell Renal Cell Carcinoma. Analytical Cellular Pathology, 2022, 1-32. https://doi.org/10.1155/2022/4673514
Vancouver
Zhang W, Wang H, Wang W, Xue H, Qiao M, Song L, et al. A Cuproptosis-Related lncRNAs Signature Could Accurately Predict Prognosis in Patients with Clear Cell Renal Cell Carcinoma. Analytical Cellular Pathology. 2022;2022:1-32. doi:10.1155/2022/4673514
BibTeX
@article{Zhang2022,
author = {Zhang, Wei and Wang, Han and Wang, Wei and Xue, Haoqiang and Qiao, Maolin and Song, Liying and Wang, Shuang and Ren, Zhaoyu and Ma, Zhifang},
title = {A Cuproptosis-Related lncRNAs Signature Could Accurately Predict Prognosis in Patients with Clear Cell Renal Cell Carcinoma},
journal = {Analytical Cellular Pathology},
year = {2022},
volume = {2022},
pages = {1--32},
doi = {10.1155/2022/4673514}
}
EUVIMED